Back to Newsroom

International Stem Cell Corporation Announces Positive Efficacy Results in Traumatic Brain Injury

CARLSBAD, Calif., Oct. 18, 2016 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, announced today that the company’s proprietary ISC-hpNSC® readily expandable neural stem cells improved cognitive performance and motor coordination in rodents with traumatic brain injury. The study was conducted by Distinguished Professor Cesar Borlongan, Vice-Chairman for Research Department of Neurosurgery and Brain Repair and Director of Center of Excellence for Aging and Brain Repair, University of South Florida Morsani College of Medicine.

Click here to read the full release